微生物组科学在感染性疾病与抗菌药物耐药交叉领域的研究现状
本文综述了微生物组科学在感染性疾病与抗菌药物耐药交叉领域的研究现状,指出微生物群落变化是多种公共卫生威胁的共同发病机制。基础研究进展有望通过预防策略、诊断和治疗途径实现临床转化,例如针对艰难梭菌感染已应用靶向抗生素管理和粪菌移植治疗复发疾病。
要点
- 微生物群落变化是感染性疾病与抗菌药物耐药等公共卫生威胁的共同发病机制。
- 基础研究进展有望通过预防策略、诊断和治疗途径实现临床转化。
- 艰难梭菌感染已通过靶向抗生素管理和粪菌移植治疗复发疾病实现临床转化。
核心结论
- 微生物群落变化是感染性疾病与抗菌药物耐药等多种公共卫生威胁的共同发病机制,基础研究有望早期转化为预防、诊断和治疗策略。
主要发现
- 微生物群落变化是多种公共卫生威胁的共同发病机制。
- 基础研究有望通过预防策略、诊断和治疗途径实现临床转化。
- 艰难梭菌感染已通过靶向抗生素管理和粪菌移植治疗复发疾病实现临床转化。
临床怎么用
- 针对艰难梭菌感染可采用靶向抗生素管理和粪菌移植治疗复发疾病。
- 微生物组基础研究进展有望为感染性疾病提供预防、诊断和治疗新策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Along with the rise in modern chronic diseases, ranging from diabetes to asthma, there are challenges posed by increasing antibiotic resistance, which results in difficult-to-treat infections, as well as sepsis. An emerging and unifying theme in the pathogenesis of these diverse public health threats is changes in the microbial communities that inhabit multiple body sites. Although there is great promise in exploring the role of these microbial communities in chronic disease pathogenesis, the shorter timeframe of most infectious disease pathogenesis may allow early translation of our basic scientific understanding of microbial ecology and host-microbiota-pathogen interactions. Likely translation avenues include development of preventive strategies, diagnostics, and therapeutics. For example, as basic research related to microbial pathogenesis continues to progress, Clostridioides difficile infection is already being addressed clinically through at least 2 of these 3 avenues: targeted antibiotic stewardship and treatment of recurrent disease through fecal microbiota transplantation.
引用
- Ranallo RT, McDonald LC, Halpin AL, et al. The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance. J Infect Dis. 2021. PMID: 33667294. doi:10.1093/infdis/jiab020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。